ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3243

A Randomized Controlled Trial for a Physical Activity Intervention for RA Fatigue

Patricia P. Katz1, Mary Margaretten2, Steven Gregorich1, Sandi Kaplan3, Stephanie Rush4 and Laura Trupin1, 1Medicine, University of California San Francisco, San Francisco, CA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Arthritis Research Group, University of California, San Francisco, CA, 4University of California, San Francisco, San Francisco, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fatigue, physical activity and rheumatoid arthritis, treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 11, 2015

Title: ARHP V: Physical Activity

Session Type: ARHP Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Fatigue is a major problem for people with RA.  Physical inactivity is an indirect risk factor for fatigue1. We tested the effect of a simple pedometer-based physical activity intervention to reduce fatigue in people with RA.

Methods: Individuals with rheumatologist-diagnosed RA were recruited from previous studies or rheumatology clinics. Eligibility criteria were:  English- or Spanish-speaking, able to walk, able to return for study visits, at least moderate level of fatigue, and not currently engaged in regular exercise.  Eligible individuals completed baseline questionnaires and received activity-monitoring devices for a one-week baseline step count. After one week, subjects returned and were randomized into one of three groups:  (1) Education only (control), (2) Pedometer and step diary, or (3) Pedometer, step diary, and step targets. Step targets were based on the baseline step counts with the goal of increasing steps by 10% every two weeks. Groups 2 and 3 received phone calls every two weeks to collect step diary information and, for Group 3, to assign new step targets. Follow-up assessments were made at Week 10 (by phone) and Week 21 (in person). The primary outcome was fatigue measured with the PROMIS Fatigue short-form. Changes in the number of steps and in fatigue were tested within each group using paired t-tests and across groups with linear regression using Group 1 (education only) as the reference group.

Results: 359 individuals were approached to participate; 91 refused before screening, 150 were ineligible, and 22 were eligible but refused, leaving 96 participants. Mean ±SD age of participants was 54 ±13 years, 88% were female, and 21% were Spanish-speaking. Mean RA duration was 14 ±13 years.  At baseline, mean RA Disease Activity Index (RADAI) was 4.1 ±1.9, mean HAQ was 1.34 ± 0.65, 59% were currently using glucocorticoids, and 60% were currently receiving biologics. Overall, the median of the average number of daily steps at baseline was 3710 (<5000 is considered “sedentary”) and mean fatigue score was 59.0 ±6.9.  At 21 weeks, both intervention groups had significant increases in mean daily steps compared to the control group (p<.05; table).  Only Group 3 achieved a significant increase in steps as a proportion of baseline.  Both intervention groups had significant and meaningful decreases in fatigue (p<.05, table). Across all groups, decreases in fatigue were correlated with the percentage increase in average daily steps (r = -0.37, p = .005).

Conclusion: A low-resource, pedometer-based physical activity intervention yielded significant increases in physical activity and significant decreases in fatigue among individuals with RA. Results suggest that increasing physical activity by prescribing a pedometer can be effective for reducing fatigue, particularly among individuals with very low activity levels initially.

1Katz et al. Arthritis Care Res [epub 2015 Mar 16]

 

 

Group 1:

Education

Group 2: Pedometer

Group 3:

Pedometer + step targets

N (at baseline)

 

28

34

34

Baseline steps

 

 

 

     Median (IQR)

5055 (3162, 7842)

2956 (1847, 5189)

3417 (1988, 6693)

     Mean ± SD

5653 ± 3823*

3653 ± 2484

5418 ± 5214

Baseline fatigue†

 

57.6 ± 7.6

59.7 ± 6.5

60.0 ± 6.4

Changes, baseline to 21 weeks

 

 

 

     Δ steps (number)

 

-327 ± 2429

(p = .53)§

2132 ± 2698

(p = .002)

1299 ± 2389

(p = .02)

     Δ steps (% increase from      baseline)

3% ± 56

92% ± 125

188% ± 506

     Δ fatigue

-2.3 ± 8.4

(p = .23)

-3.8 ± 7.6

(p = .04)

-5.1 ± 9.2

(p = .02)

* All values are mean ± SD except median (IQR) of baseline steps

† PROMIS Fatigue scores have a population mean of 50 and standard deviation of 10.  Higher scores reflect greater fatigue.

§ p-values obtained from paired t-test comparing baseline and 21-week follow-up within each group.


Disclosure: P. P. Katz, None; M. Margaretten, None; S. Gregorich, None; S. Kaplan, None; S. Rush, None; L. Trupin, None.

To cite this abstract in AMA style:

Katz PP, Margaretten M, Gregorich S, Kaplan S, Rush S, Trupin L. A Randomized Controlled Trial for a Physical Activity Intervention for RA Fatigue [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-randomized-controlled-trial-for-a-physical-activity-intervention-for-ra-fatigue/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-randomized-controlled-trial-for-a-physical-activity-intervention-for-ra-fatigue/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology